Replies to post #168929 on NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

The speculation about it began with the discovery of "the planned publication of interim clinical trial data" having been added to the growing list of formal information requests that have been made by the SEC as it was written in the 10K.

U.S. Securities and Exchange Commission

As previously reported, the Company has received a number formal information requests (subpoenas) from the SEC regarding several broad topics that have been previously disclosed, including the Company’s membership on Nasdaq and delisting, related party matters, the Company’s programs, internal controls, the Company’s Special Litigation Committee, disclosures and the planned publication of interim clinical trial data. Testimony of certain officers and third parties has been taken as well. The Company is cooperating with the SEC investigation and is hopeful that it is reaching its final stages.

It's purely speculation as to what it really means - what can be said is that while the list grows longer and longer as to what the SEC has requested information for - nothing seems to come from it. It's each shareholder's choice as to whether they are concerned about it. My choice is to not be.